Home

Actuate Therapeutics, Inc. - Common stock (ACTU)

7.0300
+0.3900 (5.87%)
NASDAQ · Last Trade: Sep 22nd, 12:37 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Actuate Therapeutics Stock Rises After Updating FDA Application For Lead Investigational Drug In Treating Pancreatic Cancerstocktwits.com
Actuate on Monday also said that its recent $17.25 million public offering provides an extended runway into the second half of 2026.
Via Stocktwits · September 22, 2025
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · September 10, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · September 10, 2025
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · September 9, 2025
This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesdaybenzinga.com
Via Benzinga · August 26, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 27, 2025
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · June 26, 2025
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · January 28, 2025
Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · December 13, 2024
Pheton, Powell Max Make Public Debuttalkmarkets.com
Pheton Holdings and Powell Max opened for trading on Thursday at $3.76 and $4.30, respectively. While the number of initial public offerings has rebounded from 2023, IPOs remain well below pre-pandemic levels.
Via Talk Markets · September 8, 2024
Actuate Therapeutics Makes Public Debuttalkmarkets.com
Actuate Therapeutics opened on Aug. 13 at $9.88. The biopharmaceutical company had priced its initial public offering of 2.8 million shares at a price of $8.00 per share.
Via Talk Markets · August 18, 2024